CD43 IHC Test for T-Cell Tumors | Lahalak Platform
A versatile diagnostic package to differentiate between lymphoid and myeloid tumor types, providing high accuracy in tumor classification to help select the most appropriate chemotherapy or targeted therapy.
Scientific name: Immunohistochemistry: CD43 Diagnostic Package
This diagnostic package, based on immunohistochemistry, includes the testing of a range of markers to evaluate lymphocyte and myeloproliferative proliferations. The package primarily includes testing for CD43 (leukosialin), a membrane marker expressed by T cells, myelocytes (phagocytes), mast cells, and some B cells, as well as the essential comple...
Service type
Immunohistochemistry (IHC) Diagnostic Package
Duration
20-30 minutes
Fasting
Fasting is not required
Included Services
- Checking for the general CD43 marker on suspicious cells.
- Specific markers were examined to determine the strain: CD3 (T), CD20 (B), and MPO or Lysozyme (myeloid/phagocytic).
- Consult a pathologist specializing in blood and lymphatic tumors for a comprehensive interpretation of the results.
- Personal support services from Lahalak
Medical Service Information
Conditions & Notices
- It requires the submission of a complete tissue block (paraffin block) of the biopsy specimen (lymph node, skin, bone marrow, etc.).
- It is necessary to attach the initial pathology report along with a description of the tissue under examination.
- The patient does not need to fast, as the sample is tissue-based.
- The completion time ranges from 5 to 10 working days.
Medical services you might also like
